Nektar Therapeutics (NQ: NKTR )

17.22 USD +0.24 (+1.41%)

Official Closing Price Updated: 4:46 PM EST, Jan 19, 2021 Add to My Watchlist

Price and Volume

Volume	1,229,655
Open	17.13
Bid (Size)	16.50 (1)
Ask (Size)	17.32 (1)
Prev. Close	16.98
Today's Range	16.73 - 17.29
52wk Range	13.63 - 25.06
Shares Outstanding	171,402,476
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Nektar Therapeutics' President and CEO, Howard Robin, to Present at the 39th Annual J.P. Morgan Virtual Healthcare Conference

January 06, 2021

Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard Robin, is scheduled to present at the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference on Monday, January...

Nektar Appoints Dr. Brian Kotzin as Interim Chief Medical Officer and Head of Development

January 05, 2021

Nektar Therapeutics (NASDAQ: NKTR) announced today that it has appointed Brian Kotzin, MD as Interim Chief Medical Officer, Head of Development effective immediately. Since 2017, Dr. Kotzin has served...

Performance

YTD	-2.49%	-2.49%
1 Month	-7.67%	-7.67%
3 Month	+2.07%	+2.07%
6 Month	-29.94%	-29.94%
1 Year	-23.19%	-23.19%

More News

Nektar Therapeutics Announces Agreement with Healthcare Royalty to Sell ADYNOVATE® and MOVANTIK® Royalties for $150 Million

December 22, 2020

Nektar Therapeutics Announces Dosing of First Patients in Phase 1/2 Study of its IL-15 Agonist, NKTR-255, in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma or Colore

December 15, 2020

SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of EQT, ZYNE, NKTR, and FMO; Shareholders are Encouraged to Contact the Firm

December 08, 2020

Nektar Therapeutics Announces Presentation of Preclinical Data for NKTR-255, its Novel IL-15 Agonist, at the American Society of Hematology (ASH) 2020 Annual Meeting

December 07, 2020

First Week of NKTR March 19th Options Trading

January 15, 2021

Nektar Therapeutics Presents New Data from Its Immuno-Oncology Pipeline at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 11, 2020

How The Pieces Add Up: FBT Targets $202

January 11, 2021

February 26th Options Now Available For Nektar Therapeutics (NKTR)

January 07, 2021

February 2021 Options Now Available For Nektar Therapeutics (NKTR)

December 24, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.